Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 187739-60-2
2. 776c212qqh
3. Carboxyamidotriazole (orotate)
4. 5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]triazole-4-carboxamide;2,4-dioxo-1h-pyrimidine-6-carboxylic Acid
5. 4-pyrimidinecarboxylic Acid, 1,2,3,6-tetrahydro-2,6-dioxo-, Compd. With 5-amino-1-((3,5-dichloro-4-(4-chlorobenzoyl)phenyl)methyl)-1h-1,2,3-triazole-4-carboxamide (1:1)
6. 5-amino-1-(3,5-dichloro-4-(4-chlorobenzoyl)benzyl)-1h-1,2,3-triazole-4-carboxamide 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate
7. Cto
8. Cai Orotate
9. L-651582 Orotate
10. Unii-776c212qqh
11. Schembl7924972
12. Cai Orotatel-651582 Orotate
13. Ex-a5646
14. Hy-16125
15. Cs-0006151
Molecular Weight | 580.8 g/mol |
---|---|
Molecular Formula | C22H16Cl3N7O6 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 6 |
Exact Mass | 579.022764 g/mol |
Monoisotopic Mass | 579.022764 g/mol |
Topological Polar Surface Area | 212 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 816 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
37
PharmaCompass offers a list of Carboxyamidotriazole Orotate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carboxyamidotriazole Orotate manufacturer or Carboxyamidotriazole Orotate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carboxyamidotriazole Orotate manufacturer or Carboxyamidotriazole Orotate supplier.
PharmaCompass also assists you with knowing the Carboxyamidotriazole Orotate API Price utilized in the formulation of products. Carboxyamidotriazole Orotate API Price is not always fixed or binding as the Carboxyamidotriazole Orotate Price is obtained through a variety of data sources. The Carboxyamidotriazole Orotate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Carboxyamidotriazole Orotate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carboxyamidotriazole Orotate, including repackagers and relabelers. The FDA regulates Carboxyamidotriazole Orotate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carboxyamidotriazole Orotate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Carboxyamidotriazole Orotate supplier is an individual or a company that provides Carboxyamidotriazole Orotate active pharmaceutical ingredient (API) or Carboxyamidotriazole Orotate finished formulations upon request. The Carboxyamidotriazole Orotate suppliers may include Carboxyamidotriazole Orotate API manufacturers, exporters, distributors and traders.
Carboxyamidotriazole Orotate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carboxyamidotriazole Orotate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Carboxyamidotriazole Orotate GMP manufacturer or Carboxyamidotriazole Orotate GMP API supplier for your needs.
A Carboxyamidotriazole Orotate CoA (Certificate of Analysis) is a formal document that attests to Carboxyamidotriazole Orotate's compliance with Carboxyamidotriazole Orotate specifications and serves as a tool for batch-level quality control.
Carboxyamidotriazole Orotate CoA mostly includes findings from lab analyses of a specific batch. For each Carboxyamidotriazole Orotate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carboxyamidotriazole Orotate may be tested according to a variety of international standards, such as European Pharmacopoeia (Carboxyamidotriazole Orotate EP), Carboxyamidotriazole Orotate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carboxyamidotriazole Orotate USP).